APA

Ouvry G., Atrux-Tallau N., Bihl F., Bondu A., Bouix-Peter C., Carlavan I., Christin O., Cuadrado M., Defoin-Platel C., Deret S., Duvert D., Feret C., Forissier M., Fournier J., Froude D., Hacini-Rachinel F., Harris C. S., Hervouet C., Huguet H., Lafitte G., Luzy A., Musicki B., Orfila D., Ozello B., Pascau C., Pascau J., Parnet V., Peluchon G., Pierre R., Piwnica D., Raffin C., Rossio P., Spiesse D., Taquet N., Thoreau E., Vatinel R., Vial E. & Hennequin L. F. (20190122). Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis. : ChemMedChem.

Chicago

Ouvry Gilles, Atrux-Tallau Nicolas, Bihl Franck, Bondu Aline, Bouix-Peter Claire, Carlavan Isabelle, Christin Olivier, Cuadrado Marie-Josée, Defoin-Platel Claire, Deret Sophie, Duvert Denis, Feret Christophe, Forissier Mathieu, Fournier Jean-François, Froude David, Hacini-Rachinel Fériel, Harris Craig Steven, Hervouet Catherine, Huguet Hélène, Lafitte Guillaume, Luzy Anne-Pascale, Musicki Branislav, Orfila Danielle, Ozello Benjamin, Pascau Coralie, Pascau Jonathan, Parnet Véronique, Peluchon Guillaume, Pierre Romain, Piwnica David, Raffin Catherine, Rossio Patricia, Spiesse Delphine, Taquet Nathalie, Thoreau Etienne, Vatinel Rodolphe, Vial Emmanuel and Hennequin Laurent François. 20190122. Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis. : ChemMedChem.

Harvard

Ouvry G., Atrux-Tallau N., Bihl F., Bondu A., Bouix-Peter C., Carlavan I., Christin O., Cuadrado M., Defoin-Platel C., Deret S., Duvert D., Feret C., Forissier M., Fournier J., Froude D., Hacini-Rachinel F., Harris C. S., Hervouet C., Huguet H., Lafitte G., Luzy A., Musicki B., Orfila D., Ozello B., Pascau C., Pascau J., Parnet V., Peluchon G., Pierre R., Piwnica D., Raffin C., Rossio P., Spiesse D., Taquet N., Thoreau E., Vatinel R., Vial E. and Hennequin L. F. (20190122). Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis. : ChemMedChem.

MLA

Ouvry Gilles, Atrux-Tallau Nicolas, Bihl Franck, Bondu Aline, Bouix-Peter Claire, Carlavan Isabelle, Christin Olivier, Cuadrado Marie-Josée, Defoin-Platel Claire, Deret Sophie, Duvert Denis, Feret Christophe, Forissier Mathieu, Fournier Jean-François, Froude David, Hacini-Rachinel Fériel, Harris Craig Steven, Hervouet Catherine, Huguet Hélène, Lafitte Guillaume, Luzy Anne-Pascale, Musicki Branislav, Orfila Danielle, Ozello Benjamin, Pascau Coralie, Pascau Jonathan, Parnet Véronique, Peluchon Guillaume, Pierre Romain, Piwnica David, Raffin Catherine, Rossio Patricia, Spiesse Delphine, Taquet Nathalie, Thoreau Etienne, Vatinel Rodolphe, Vial Emmanuel and Hennequin Laurent François. Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis. : ChemMedChem. 20190122.